All SARS-CoV-2 articles – Page 16
-
NewsNew coronavirus-capturing material could transform the face mask
Researchers have developed a new material that captures coronavirus particles and could transform the efficiency of face masks.
-
NewsContagious omicron strain replicates early in infection
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsCOVID-19 could hold key to spotting viruses with pandemic potential
Certain SARS-CoV-2 variants of concern are evolving to do a better job of shutting down human innate immune responses, according to new research.
-
CareersIgnoring the rise of anti-science could usher back once-deadly diseases
As a wave of anti-science sentiment sweeps the globe, scientists need to speak up, says paediatric vaccine scientist Dr Peter Hotez in an interview with The Microbiologist as he launches his new book.
-
NewsScientists developing field test to detect Covid virus in dozens of host species
Purdue University has received $2.7 million in federal funding to develop a field test that can measure and predict the spread of SARS-CoV-2, the virus that causes COVID-19, in a wide range of wildlife and farm animals.
-
OpinionHas a viral contribution to Alzheimer’s disease been in front of our noses this whole time?
The concept that a viral infection may induce pathology in regions far from its active location is gaining traction. Could this phenomenon also be at play in Alzheimer’s disease?
-
NewsMilestone in the fight against pandemics
Researchers at TU Dresden create pioneering approaches for the detection of viral antigens.
-
NewsNew SARS-CoV-2 variant Eris on the rise
The EG.5 lineage of SARS-CoV-2, known as Eris, which has been spreading globally, has been found to be able to escape neutralizing antibodies better than other currently circulating SARS-CoV-2 lineages.
-
NewsScientists uncover COVID’s weakness - the need for human cells
New UC Riverside research has revealed COVID’s Achilles heel — its dependence on key human proteins for its replication — which can be used to prevent the virus from making people sick.
-
NewsMore people develop sepsis than we thought — but more survive
The observed increase in cases is largely due to more people developing sepsis repeatedly, rather than dying the first time they contract it, a new study reveals.
-
NewsRapid acting oral vaccines are on the way
Researchers studying SARS-CoV-2 may have developed new methods to administer vaccines orally, which would be both easier to administer and more effective at combatting illnesses.
-
CareersNew research IDs 28 genetic regions linked to susceptibility and severity of COVID-19
A study identifies 51 significant genome-wide loci associated with both COVID-19 severity and SARS-CoV-2 susceptibility, providing valuable information about the disease.
-
NewsMap the coronavirus spike protein for insight into vaccine development
A new study has found that the fusion peptide in the spike protein plays a more invasive role in fusing the virus to the cell than previously thought, which is significant in understanding how infection occurs.
-
NewsStudy helps explain SARS-CoV-2 variants’ rapid spread
Omicron variants, which circulated quickly around the globe, bind to cells more avidly and evade antibodies more efficiently than earlier variants, new research reveals.
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
-
NewsN-protein research reveals role of human body temperature in Covid proliferation
Researchers shed light on a pivotal part in the RNA-binding mechanism of the nucleocapsid protein (N) – SARS-CoV-2 probably uses human body temperature for its proliferation strategy.
-
NewsCommon cold virus exposure may help usher in immunity to Covid
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study.
